Rational Combination of Targeted Therapies As A Strategy to Overcome The Mechanisms of Resistance to Inhibitors of EGFR Signaling

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|33|3358-3367

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.33, 2007-11, pp. : 3358-3367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer

By Kenny Paraic A

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1287-1298

Informa Healthcare

Access to resources Recommend Favorite

Strategies to Overcome Resistance to Targeted Protein Kinase Inhibitors in the Treatment of Cancer

By Buschbeck Marcus

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 73-86

Adis International

Access to resources Recommend Favorite

EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance

Current Molecular Pharmacology, Vol. 3, Iss. 1, 2010-01 ,pp. : 37-52

Bentham Science Publishers

Access to resources Recommend Favorite

Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells

By Mamot Christoph Ritschard Reto Wicki Andreas Küng Willy Schuller Jan Herrmann Richard Rochlitz Christoph

Journal of Drug Targeting, Vol. 20, Iss. 5, 2012-06 ,pp. : 422-432

Informa Healthcare

Access to resources Recommend Favorite

Novel Targeted Therapies to Overcome Trastuzumab Resistance in HER2- Overexpressing Metastatic Breast Cancer

Current Drug Targets, Vol. 14, Iss. 8, 2013-07 ,pp. : 889-898

Bentham Science Publishers

Access to resources Recommend Favorite